Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Street News Service/Inter Press Service examines how Senegal is addressing HIV/AIDS among prisoners in a Dakar maximum-security facility. "Prisons are high-risk environments for the transmission of the disease, due to the prevalence of hard drugs, violence and sexual relations," the news service writes and discusses how addressing such issues can present challenges in the majority-Muslim country. "There is no mandatory testing in prison, and for those prisoners who, either knowingly or unknowingly, are living with HIV, the stresses of living in prison -- including overcrowding, unsanitary conditions, and poor nutrition -- mean their health is even more compromised."

The news service profiles Amadou, a former inmate at the prison and "a prominent gay AIDS activist, helping promote harm-reduction strategies throughout the country." The news service notes that while "Senegal has among the lowest rates of HIV in sub-Saharan Africa, at less than one percent ..., the most vulnerable group is men who have sex with men (MSM), nearly 22 percent of whom are HIV-positive" (Fortier, 1/5).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity